{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Saint Louis",
      "state": "MO",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97938",
      "recalling_firm": "Park Avenue Compounding",
      "address_1": "3662 Park Ave Ste 140",
      "address_2": "",
      "postal_code": "63110-2512",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed in Missouri",
      "recall_number": "D-0178-2026",
      "product_description": "Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII,  150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.",
      "product_quantity": "189 bags",
      "reason_for_recall": "CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.",
      "recall_initiation_date": "20250923",
      "center_classification_date": "20251120",
      "report_date": "20251126",
      "code_info": "Lot # 20250507-01D93C, Exp Date: 11-04-2025",
      "more_code_info": ""
    }
  ]
}